Suzannah J Harnor

9PUBLICATIONS
16CO-AUTHORS
Molecular targetsBiologically active moleculesBiomolecular modelling and designChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 10, 2026
Targeting DNA-PK: medicinal chemistry insights into small-molecule inhibitor discovery and optimisation.

|Apr 01, 2023
Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy.

Duncan C Miller, Suzannah J Harnor, Mathew P Martin

|Apr 25, 2022
Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain Inhibitor.

Duncan C Miller, Tristan Reuillon, Lauren Molyneux

|Jul 02, 2021
An Alkynylpyrimidine-Based Covalent Inhibitor That Targets a Unique Cysteine in NF-κB-Inducing Kinase.

Islam Al-Khawaldeh, Mohammed J Al Yasiri, Gregory G Aldred

|Mar 24, 2021
Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein Interaction.

Gianni Chessari, Ian R Hardcastle, Jong Sook Ahn

|Jan 22, 2021
2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase.

Christopher J Matheson, Christopher R Coxon, Richard Bayliss

Pageof 2

Frequent Collaborators

9 joint publications

Celine Cano

4 joint publications

Duncan C Miller

2 joint publications

Bernard T Golding

2 joint publications

Michael J Waring